Khattar Jack A.'s Form 4 filing
Supernus Pharmaceuticals, Inc. (SUPN) · filed Aug 8, 2025
- Accession no.
- 0001628280-25-039302
- Filed
- Aug 8, 2025
- Trade date
- Aug 6, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $5.88M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Khattar Jack A.CIK 0001539937 | Director, Officer (President, CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 6, 2025 | Common Stock | MOption exerciseAcquired | +60,000 | $12.98 | +$778,800 | 1,068,683 | Direct | |
| Aug 6, 2025 | Common Stock | SSaleDisposed | −38,500 | $40.24 | −$1,549,240 | 1,030,183 | Direct | |
| Aug 6, 2025 | Common Stock | MOption exerciseAcquired | +60,000 | $12.98 | +$778,800 | 1,090,183 | Direct | |
| Aug 6, 2025 | Common Stock | SSaleDisposed | −38,000 | $42.00 | −$1,596,000 | 1,052,183 | Direct | |
| Aug 6, 2025 | Common Stock | MOption exerciseAcquired | +81,250 | $25.30 | +$2,055,625 | 1,133,433 | Direct | |
| Aug 6, 2025 | Common Stock | SSaleDisposed | −63,500 | $43.12 | −$2,738,120 | 1,069,933 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 6, 2025 | Common Stock | MOption exerciseDisposed | −60,000 | $0.00 | $0 | 195,000 | Direct | |
| Aug 6, 2025 | Common Stock | MOption exerciseDisposed | −60,000 | $0.00 | $0 | 135,000 | Direct | |
| Aug 6, 2025 | Common Stock | MOption exerciseDisposed | −81,250 | $0.00 | $0 | 243,750 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.